Ampio Pharmaceuticals, Inc. (NYSEAMERICAN:AMPE – Get Rating)’s share price passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.29 and traded as low as $0.22. Ampio Pharmaceuticals shares last traded at $0.22, with a volume of 124,662 shares trading hands.
Analysts Set New Price Targets
Separately, StockNews.com assumed coverage on Ampio Pharmaceuticals in a research note on Friday. They set a “sell” rating on the stock.
Ampio Pharmaceuticals Stock Down 26.7 %
The stock has a market cap of $3.32 million, a PE ratio of -0.12 and a beta of 1.48. The business has a 50 day moving average price of $0.29 and a 200 day moving average price of $0.20.
Institutional Trading of Ampio Pharmaceuticals
About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease.
- Get a free copy of the StockNews.com research report on Ampio Pharmaceuticals (AMPE)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.